Medicenna Therapeutics (NASDAQ:MDNA) posted its earnings results on Friday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.04) by ($0.02), reports.
MDNA opened at $3.72 on Monday. The business’s 50 day simple moving average is $4.03. The firm has a market cap of $182.00 million, a P/E ratio of -19.58 and a beta of 1.81. Medicenna Therapeutics has a 1 year low of $0.98 and a 1 year high of $5.32.
Medicenna Therapeutics Company Profile
Read More: Stock Portfolio Tracker
Receive News & Ratings for Medicenna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicenna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.